Stated and Revealed Preferences for Funding New High-Cost Cancer Drugs: A Critical Review of the Evidence from Patients, the Public and Payers-Reference-Cited by-同舟云学术

Stated and Revealed Preferences for Funding New High-Cost Cancer Drugs: A Critical Review of the Evidence from Patients, the Public and Payers

Published:2015-09-14 Issue:3 Volume:9 Page:201-222
ISSN:1178-1653
Container-title:The Patient - Patient-Centered Outcomes Research
language:en
Short-container-title:Patient

Author:

MacLeod Tatjana E.,Harris Anthony H.,Mahal Ajay

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1007/s40271-015-0139-7.pdf

Reference79 articles.

1. World Health Organization. The World Health Report 2002: reducing risks, promoting healthy life. Geneva: World Health Organization.

2. Sorenson C, Drummond M, Kanavos P. Ensuring value for money in healthcare: the role of health technology assessment in the European Union. European observatory on health systems and policies. Observatory studies series No. 11. Copenhagen: WHO; 2008. http://www.euro.who.int/__data/assets/pdf_file/0011/98291/E91271.pdf . Accessed 10 Feb 2015.

3. Epstein RM, Peters E. Beyond information; exploring patients’ preferences. JAMA. 2014;302:195–7.

4. Institute of Medicine, Levit L, Balogh E, Nass S, Ganz PA. Delivering high-quality cancer care: charting a new course for a system in crisis. Washington, DC: The National Academies Press; 2013.

5. Chalkidou K, Lopert R, Gerber A. Paying for “end-of’life” drugs in Australia, Germany, and the United Kingdom: balancing policy, pragmatism, and societal values. Commonw Fund. 2012;1576:2.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preferences on Policy Options for Ensuring the Financial Sustainability of Healthcare Services in the Kingdom of Saudi Arabia;Risk Management and Healthcare Policy;2023-06

2. Public preferences regarding the priority setting criteria of health interventions for budget allocation: results of a survey of Iranian adults;BMC Public Health;2022-11-08

3. Citizens’ opinions and experiences related to costs and reimbursements for medications in times of retrenchment: cross-sectional population surveys in 2015 and 2017;International Journal for Equity in Health;2022-03-09

4. A pilot study to explore societal, patient, and public authority perception on ‘Value-Added Tax’ system for healthcare financing in Zimbabwe: A case for cancer treatment;Journal of Oncology Pharmacy Practice;2022-01-27

5. Introduction to the Imaginary of Precision Oncology;Human Perspectives in Health Sciences and Technology;2022